H. Saitoh et al., PROMPT DECREASE OF CIRCULATING HEPATITIS-C VIRUS IN PATIENTS WITH CHRONIC HEPATITIS-C AFTER TREATMENT WITH INTERFERON, Journal of interferon research, 14(5), 1994, pp. 239-244
Patients with chronic hepatitis C were treated with interferon (IFN) a
nd followed for hepatitis C virus (HCV) RNA and antibody to HCV (anti-
HCV) in serum. The response was correlated with decrease in serum leve
ls of HCV RNA, as well as HCV genotypes and liver histopathology. Resp
onse to IFN, estimated by clearance of HCV RNA and normalization of am
inotransferase levels at 6 months after the withdrawal of IFN, was obs
erved in 11 (31%) of 35 patients infected with HCV of genotype II/1b,
13 (72%) of 18 with genotype III/2a, and 2 (33%) of 6 with genotype IV
/2b; a single patient with genotype I/1a responded while the one doubl
y infected with HCV of genotypes II/1b and IV/2b did not. Response was
seen in 10 (71%) of 14 patients with chronic persistent hepatitis, 14
(39%) of 36 with chronic active hepatitis 2A, and 3 (27%) of 11 with
2B. Response was achieved less often in patients with high than low pr
etreatment levels of HCV RNA. HCV RNA dropped sharply on a day after t
he start of IFN, and continued to decrease during the 2 weeks, irrespe
ctive of the response to IFN or HCV genotypes. In contrast, anti-HCV d
ecreased more gradually and only in responders to IFN. These results s
upport the rapid development of an IFN-mediated antiviral effect on HC
V, and support therapeutic effects of IFN dependent on histopathology
of liver as well as HCV RNA titers and genotypes,